Thursday, 20 March 2014

Type 2 diabetes: empagliflozin

Evidence summary (NICE)


Novartis introduces Lucentis® in state of the art pre-filled syringe

Epecifically designed for intraocular injection (Novartis)


Multiple Non-glycemic Genomic Loci Are Newly Associated with Blood Level of Glycated Hemoglobin in East Asians

Variants affecting erythrocyte parameters rather than glucose metabolism may be relevant to the use of HbA1C for diagnosing diabetes in these populations (Diabetes)


Chronic Dipeptidyl Peptidase-4 Inhibition With Sitagliptin Is Associated With Sustained Protection Against Ischemic Left Ventricular Dysfunction

The addition of dipeptidyl peptidase-4 inhibitor therapy with sitagliptin to the treatment regime of patients with type 2 diabetes mellitus and coronary artery disease is associated with a sustained improvement in myocardial performance during dobutamine stress and a reduction in postischemic stunning (Circulation: Cardiovascular Imaging)

No comments:

Post a Comment